CRP and diabetes mellitus: However, Lp-PLA2 may, synergistically to CRP, contribute to better risk assessment and guided management in patients with specific characteristics and complementary to established risk factors, e.g. patients with very high baseline LDL-values, with diabetes mellitus or history of cardiovascular events [25].